The Canadian Cancer Society recommends that average-risk individuals consider screening with the PSA test starting at age 50.

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Prostate cancer is one of the most common cancers affecting men globally, with African men facing a disproportionate burden of the disease.

A prostate cancer testing event was held recently at the Frome Masonic Hall, where 236 men were tested. Organised by ...

Over 100 prostate-specific antigen (PSA) tests have been conducted in highways depots and at County Hall in Taunton following a programme spearheaded by Somerset Council and Kier, the local highways ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively ...